These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 17347574

  • 1. Unexpected phenotype of STAT6 heterozygous mice implies distinct STAT6 dosage requirements for different IL-4 functions.
    Burgis S, Gessner A.
    Int Arch Allergy Immunol; 2007; 143(4):263-8. PubMed ID: 17347574
    [Abstract] [Full Text] [Related]

  • 2. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major.
    Dent AL, Doherty TM, Paul WE, Sher A, Staudt LM.
    J Immunol; 1999 Aug 15; 163(4):2098-103. PubMed ID: 10438949
    [Abstract] [Full Text] [Related]

  • 3. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination.
    Linehan LA, Warren WD, Thompson PA, Grusby MJ, Berton MT.
    J Immunol; 1998 Jul 01; 161(1):302-10. PubMed ID: 9647237
    [Abstract] [Full Text] [Related]

  • 4. In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.
    Morris SC, Coffman RL, Finkelman FD.
    J Immunol; 1998 Apr 01; 160(7):3299-304. PubMed ID: 9531287
    [Abstract] [Full Text] [Related]

  • 5. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR.
    Int Immunol; 2005 Oct 01; 17(10):1347-57. PubMed ID: 16141242
    [Abstract] [Full Text] [Related]

  • 6. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB.
    Int Immunol; 2004 May 01; 16(5):685-95. PubMed ID: 15096484
    [Abstract] [Full Text] [Related]

  • 7. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
    Stamm LM, Räisänen-Sokolowski A, Okano M, Russell ME, David JR, Satoskar AR.
    J Immunol; 1998 Dec 01; 161(11):6180-8. PubMed ID: 9834104
    [Abstract] [Full Text] [Related]

  • 8. Essential role of Stat6 in IL-4 signalling.
    Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S.
    Nature; 1996 Apr 18; 380(6575):627-30. PubMed ID: 8602263
    [Abstract] [Full Text] [Related]

  • 9. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6.
    Yoshimoto T, Mizutani H, Tsutsui H, Noben-Trauth N, Yamanaka K, Tanaka M, Izumi S, Okamura H, Paul WE, Nakanishi K.
    Nat Immunol; 2000 Aug 18; 1(2):132-7. PubMed ID: 11248805
    [Abstract] [Full Text] [Related]

  • 10. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.
    Deboy CA, Xin J, Byram SC, Serpe CJ, Sanders VM, Jones KJ.
    Exp Neurol; 2006 Sep 18; 201(1):212-24. PubMed ID: 16806176
    [Abstract] [Full Text] [Related]

  • 11. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.
    Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN.
    Nature; 1996 Apr 18; 380(6575):630-3. PubMed ID: 8602264
    [Abstract] [Full Text] [Related]

  • 12. Expression of IL-4 receptor on non-bone marrow-derived cells is necessary for the timely elimination of Strongyloides venezuelensis in mice, but not for intestinal IL-4 production.
    Negrão-Corrêa D, Pinho V, Souza DG, Pereira AT, Fernandes A, Scheuermann K, Souza AL, Teixeira MM.
    Int J Parasitol; 2006 Sep 18; 36(10-11):1185-95. PubMed ID: 16793046
    [Abstract] [Full Text] [Related]

  • 13. Identification of novel Stat6 regulated proteins in IL-4-treated mouse lymphocytes.
    Tuomela S, Rautajoki KJ, Moulder R, Nyman TA, Lahesmaa R.
    Proteomics; 2009 Feb 18; 9(4):1087-98. PubMed ID: 19180534
    [Abstract] [Full Text] [Related]

  • 14. Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice.
    Darcan-Nicolaisen Y, Meinicke H, Fels G, Hegend O, Haberland A, Kühl A, Loddenkemper C, Witzenrath M, Kube S, Henke W, Hamelmann E.
    J Immunol; 2009 Jun 15; 182(12):7501-8. PubMed ID: 19494273
    [Abstract] [Full Text] [Related]

  • 15. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
    Gumy A, Aseffa A, Rachinel N, Breton M, Otten L, Tacchini-Cottier F, Röcken M, Doyen N, Acha-Orbea H, Locksley RM, MacDonald HR, Launois P, Louis J.
    Eur J Immunol; 2006 Jun 15; 36(6):1465-73. PubMed ID: 16637008
    [Abstract] [Full Text] [Related]

  • 16. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice.
    Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S.
    J Immunol; 1996 Oct 15; 157(8):3220-2. PubMed ID: 8871614
    [Abstract] [Full Text] [Related]

  • 17. No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo.
    Hjulström S, Landin A, Jansson L, Holmdahl R, Heyman B.
    Eur J Immunol; 1995 May 15; 25(5):1469-72. PubMed ID: 7774652
    [Abstract] [Full Text] [Related]

  • 18. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background.
    Lau M, Tsantikos E, Maxwell MJ, Tarlinton DM, Anderson GP, Hibbs ML.
    J Autoimmun; 2012 Dec 15; 39(4):388-97. PubMed ID: 22867713
    [Abstract] [Full Text] [Related]

  • 19. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study.
    Hirota JA, Ask K, Fritz D, Ellis R, Wattie J, Richards CD, Labiris R, Kolb M, Inman MD.
    Clin Exp Allergy; 2009 Jan 15; 39(1):147-58. PubMed ID: 19032363
    [Abstract] [Full Text] [Related]

  • 20. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression.
    Schedel M, Frei R, Bieli C, Cameron L, Adamski J, Lauener R, Kabesch M.
    J Allergy Clin Immunol; 2009 Sep 15; 124(3):583-9, 589.e1-6. PubMed ID: 19665768
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.